References
- Periston J G, Pounder R E. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996; 10: 83–9
- Hungin APS, Gunn S D, Bate C M, Turbitt M L, Wilcock C, Richardson PDI. A comparison of the efficacy of omeprazole 20 mg once daily with ranitidine 150mg bd in the relief of symptomatic gastro-oesophageal reflux disease in General Practice. Br J Clin Res 1993; 4: 73–88
- Bate C M, Booth S N, Crowe J P, Hepworth-Jones B, Taylor M D, Richardson PDI. Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis?. Aliment Pharmacol Ther 1993; 7: 501–8
- Green JRB, Tildesley G, Theodossi A, Bate C M, Copeman M B, Taylor M D, et al. Omeprazole 20 mg to 40 mg once daily is more effective than ranitidine 300 mg to 600 mg daily in providing complete symptom relief and endoscopic healing in patients with reflux oesophagitis. Br J Clin Res 1995; 6: 63–76
- Ouyo J-B, Lang F, Fontolliet C, Monnier P. Savary-Miller's new reproducible, logical, complete and useful classification. Gastroenterology 1990; 98: A100
- Bate C M, Booth S N, Crowe J P, Mountford R A, Keeling PWN, Hepworth-Jones B, et al. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Gut 1995; 36: 492–8
- Bardhan K D, Cherian P, Vaishnavi A, Jones R B, Thompson M, Morris P, et al. Erosive esophagitis: outcome of repeated long-term treatment with low dose omeprazole lOmg or placebo. Gastroenterology 1995; 108: A53
- Hetzel D J, Dent J, Reed W D, Narielvala F M, Mackinnon M, McCarthy J H, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–12
- Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988; 23: 625–32
- Koelz H R. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials. Scand J Gastroenterol 1989; 24: 25–36, Suppl 156
- Bright-Asare P, Behar J, Brand D L, Brown F C, Castell D O, Cohen S, et al. Effects of long term maintenance cimetidine therapy on gastroesophageal reflux disease (GERD) [abstract]. Gastroenterology 1982; 82(5 pt 2)1025
- McCallum R W, Sontag S J, Vlahcevic Z R, Robinson M G, On W C, Zimmerman T W, et al. Ranitidine versus placebo in long-term treatment of gastroesophageal reflux (GERD) [abstract]. Am J Gastroenterol 1985; 80: 864
- Hallerback B, Unge P, Carling L, Edwin B, Glise H, Havu N, et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 1994; 107: 1305–11
- Dupuy H J. The Psychological General Well-Being (PGWB) Index. Assessment of quality of life in clinical trials of cardiovascular therapies, NK Wenger, ME Mattson, CD Furberg, J Elinsson. Le Jacq Publishing Inc., New York 1984; 170–83
- Svedlund J, Sjodin I, Dotevall G. GSRS–a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 129–34